Research & Publications
Evidence Over Press Releases
DIA 2026 Annual Meeting — Accepted Presentation
Abstract ID 116114Track 02
Philadelphia, PAJune 14-18, 2026
Our research on regulatory AI for trial activation has been accepted for presentation at DIA 2026. This validates Trial Activation Intelligence at the highest level of clinical trial industry discourse.
NexTrial Dispatch
Category-defining thought leadership on Trial Activation Intelligence.
Defining Trial Activation Intelligence
TAI is the intelligence layer that makes trial startup predictable. From protocol to First Patient In.